Company / Operating Income per Share
Mereo BioPharma Group plc Operating Income per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.05
FY2025
5-year range
-$0.07 / -$0.05
FY2023-FY2025
Trend
+24.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.05 to $-0.05 over the past 2 years.
Based on SEC 10-K filings.
-0.05 in FY2025.
Declined from $-0.05 to $-0.05 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 24.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -7.87 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.05 | +24.5% |
| FY2024 | -$0.07 | -52.5% |
| FY2023 | -$0.05 | - |
As of FY2025 · SEC 10-K · Updated Jun 27, 2026